OPRD1 Antikörper (pSer363) (Biotin)
Kurzübersicht für OPRD1 Antikörper (pSer363) (Biotin) (ABIN2690259)
Target
Alle OPRD1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer363
-
Spezifität
- This phosphorylation site is homologous in the listed cross reactive species at the specified location.
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Cow,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human OPRD1 around the phosphorylation site of TP(p-S)DG
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- OPRD1 (Opioid Receptor, delta 1 (OPRD1))
-
Andere Bezeichnung
- OPRD1
-
Hintergrund
-
Synonyms: OPRD, Delta-type opioid receptor, D-OR-1, DOR-1, OPRD1
Background: G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
-
Gen-ID
- 4985
-
UniProt
- P41143
-
Pathways
- Protein targeting to Nucleus
Target
-